logo.jpg
Sanofi: Availability of the Q2 2021 Memorandum for modelling purposes
June 25, 2021 01:30 ET | Sanofi
        Availability of the Q2 2021 Memorandum for modelling purposes   Paris, France – June 25, 2020 - Sanofi announced today that its Q2 2021 Memorandum for modelling purposes is available on the...
logo.gif
BGHL (EUR): NAV(s)
June 25, 2021 01:30 ET | BOUSSARD AND GAVAUDAN HOLDING LIMITED (EUR)
                                      BOUSSARD & GAVAUDAN HOLDING LIMITED Ordinary Shares The Directors of Boussard & Gavaudan Holding Limited would like to announce the following...
logo.gif
BGHL (GBP): NAV(s)
June 25, 2021 01:30 ET | BOUSSARD AND GAVAUDAN HOLDING LIMITED (GBP)
                                      BOUSSARD & GAVAUDAN HOLDING LIMITED Ordinary Shares The Directors of Boussard & Gavaudan Holding Limited would like to announce the following...
Nicox’s Licensee Bausch + Lomb Receives Approval for VYZULTA® (latanoprostene bunod ophthalmic solution), 0.024% in the United Arab Emirates
June 25, 2021 01:30 ET | NICOX
Press ReleaseNicox’s Licensee Bausch + Lomb Receives Approval for VYZULTA® (latanoprostene bunod ophthalmic solution), 0.024% in the United Arab EmiratesJune 25, 2021– release at 7:30 am CETSophia...
logo.jpg
Sanofi: Libtayo® (cemiplimab) approved by the European Commission as the first immunotherapy indicated for patients with advanced basal cell carcinoma
June 25, 2021 01:15 ET | Sanofi
  Libtayo® (cemiplimab) approved by the European Commission as the first immunotherapy indicated for patients with advanced basal cell carcinoma Approval based on data from the largest trial...
Christine Churchill Explains the Importance of a Good Customer Experience
June 25, 2021 01:15 ET | Mission Matters Business Podcast
Beverly Hills , June 25, 2021 (GLOBE NEWSWIRE) -- In this insightful interview, Christine Churchill, Founder and CEO of the Customer Service Institute of America walks us through the varying aspects...
logo.jpg
Oxurion NV to Focus Resources on Clinical Assets THR-687 and THR-149
June 25, 2021 01:00 ET | Oxurion NV
Timeline Guidance for Both Programs Confirmed Leuven, BE, Boston, MA, US – June 25, 2021 – 07.00 AM CET – Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company developing next generation...
fior-markets-logo.jpg
Global Small & Medium Caliber Ammunition Market Is Expected to Reach USD 13.4 billion by 2028 : Fior Markets
June 25, 2021 01:00 ET | Fior Markets
Newark, NJ, June 25, 2021 (GLOBE NEWSWIRE) -- As per the report published by Fior Markets, the global Small & Medium Caliber Ammunition market is expected to grow from USD 9.57 billion in 2020...
logo.jpg
Sanofi: Libtayo® (cemiplimab) approved by the European Commission for first-line treatment of patients with advanced non-small cell lung cancer with ≥50% PD-L1 expression
June 25, 2021 01:00 ET | Sanofi
          Libtayo® (cemiplimab) approved by the European Commission for first-line treatment of patients with advanced non-small cell lung cancer with ≥50% PD-L1 expression Approval based on...
Start of Day Message
June 25, 2021 01:00 ET | GlobeNewswire, Inc.
LONDON, 25 Jun. 2021 (GLOBE NEWSWIRE) -- This is the Start of Day Message for GlobeNewswire. GlobeNewswire is operated by Intrado and is designated by the FCA as an approved primary information...